Centessa Pharmaceuticals (CNTA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

16.57

-0.06%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	6.85M	-	-	-	-
Cost of Revenue	-	130.92K	33.99K	-	-
Gross Profit	6.85M	-130.92K	-33.99K	-	-
Operating Income	-171.28M	-212.26M	-139.31M	-10.44M	-5.05M
Interest Income	10.48M	7.03K	2.55K	378.00	5.00K
Pretax Income	-176.14M	-216.95M	-381.74M	-10.66M	-5.06M
Net Income	-151.09M	-216.21M	-381.85M	-11.04M	-5.28M
Selling & General & Admin	53.73M	55.20M	42.97M	1.14M	790.00K
Research & Development	124.41M	155.08M	96.31M	9.30M	4.26M
Other Expenses	-	2.34M	-	155.00K	105.00K
Operating Expenses	178.14M	210.28M	139.28M	10.44M	5.05M
Interest Expense	9.91M	7.03M	2.55M	378.00K	118.00K
Selling & Marketing Expenses	-	-	42.93M	-	-
Cost & Expenses	178.14M	210.28M	139.31M	10.44M	5.05M
Income Tax	-25.06M	-747.00K	113.99K	378.00K	223.00K
Shares Outstanding (Basic)	96.18M	93.40M	89.99M	142.06M	70.89M
Shares Outstanding (Diluted)	96.18M	93.40M	89.99M	142.06M	70.89M
EPS (Basic)	-1.57	-2.31	-4.24	-0.08	-0.07
EPS (Diluted)	-1.57	-2.31	-4.24	-0.08	-0.07
EBITDA	-166.07M	-212.26M	-379.16M	-10.43M	-4.94M
Depreciation & Amortization	5.22M	130.92K	33.99K	6.00K	6.00K